Browse > Article
http://dx.doi.org/10.5223/pghn.2019.22.4.303

Short Bowel Syndrome as the Leading Cause of Intestinal Failure in Early Life: Some Insights into the Management  

Goulet, Olivier (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School)
Nader, Elie Abi (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School)
Pigneur, Benedicte (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School)
Lambe, Cecile (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School)
Publication Information
Pediatric Gastroenterology, Hepatology & Nutrition / v.22, no.4, 2019 , pp. 303-329 More about this Journal
Abstract
Intestinal failure (IF) is the critical reduction of the gut mass or its function below the minimum needed to absorb nutrients and fluids required for adequate growth in children. Severe IF requires parenteral nutrition (PN). Pediatric IF is most commonly due to congenital or neonatal intestinal diseases or malformations divided into 3 groups: 1) reduced intestinal length and consequently reduced absorptive surface, such as in short bowel syndrome (SBS) or extensive aganglionosis; 2) abnormal development of the intestinal mucosa such as congenital diseases of enterocyte development; 3) extensive motility dysfunction such as chronic intestinal pseudo-obstruction syndromes. The leading cause of IF in childhood is the SBS. In clinical practice the degree of IF may be indirectly measured by the level of PN required for normal or catch up growth. Other indicators such as serum citrulline have not proven to be highly reliable prognostic factors in children. The last decades have allowed the development of highly sophisticated nutrient solutions consisting of optimal combinations of macronutrients and micronutrients as well as guidelines, promoting PN as a safe and efficient feeding technique. However, IF that requires long-term PN may be associated with various complications including infections, growth failure, metabolic disorders, and bone disease. IF Associated Liver Disease may be a limiting factor. However, changes in the global management of IF pediatric patients, especially since the setup of intestinal rehabilitation centres did change the prognosis thus limiting "nutritional failure" which is considered as a major indication for intestinal transplantation (ITx) or combined liver-ITx.
Keywords
Intestinal failure; Parenteral nutrition; Short bowel syndrome; Serum citrulline; Intestinal failure associated liver disease; Intestinal rehabilitation centres; GLP-2 analogs; Home parenteral nutrition; Autologous bowel reconstruction; Intestinal transplantation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118:e197-201.   DOI
2 Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg 2010;45:84-7.   DOI
3 Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr 2016;103:629S-634S.   DOI
4 Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr 2012;36:81S-94S.   DOI
5 Smith JM, Weaver T, Skeans MA, Horslen SP, Harper AM, Snyder JJ, et al. OPTN/SRTR 2016 annual data report: intestine. Am J Transplant 2018;18 Suppl 1:254-90.   DOI
6 Moreno Villares J, Galiano Segovia MJ, Marin Ferrer M. Changes in feeding behavior of patients who had received enteral nutrition during the 1st year of life. Nutr Hosp 1998;13:90-4.
7 Krom H, de Winter JP, Kindermann A. Development, prevention, and treatment of feeding tube dependency. Eur J Pediatr 2017;176:683-8.   DOI
8 Wilken M, Cremer V, Berry J, Bartmann P. Rapid home-based weaning of small children with feeding tube dependency: positive effects on feeding behaviour without deceleration of growth. Arch Dis Child 2013;98:856-61.   DOI
9 Hopkins J, Cermak SA, Merritt RJ. Oral feeding difficulties in children with short bowel syndrome: a narrative review. Nutr Clin Pract 2017:884533617707493.
10 Chiatto F, Coletta R, Aversano A, Warburton T, Forsythe L, Morabito A. Messy play therapy in the treatment of food aversion in a patient with intestinal failure: our experience. JPEN J Parenter Enteral Nutr 2019;43:412-8.   DOI
11 Leonberg BL, Chuang E, Eicher P, Tershakovec AM, Leonard L, Stallings VA. Long-term growth and development in children after home parental nutrition. J Pediatr 1998;132:461-6.   DOI
12 Olieman JF, Tibboel D, Penning C. Growth and nutritional aspects of infantile short bowel syndrome for the past 2 decades. J Pediatr Surg 2008;43:2061-9.   DOI
13 Goulet O, Antebi H, Wolf C, Talbotec C, Alcindor LG, Corriol O, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010;34:485-95.   DOI
14 El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology 2012;55:1518-28.   DOI
15 McKenna S, Gossling M, Bugarini A, Hill E, Anderson AL, Rancourt RC, et al. Endotoxemia induces $I{\kappa}B{\beta}$/NF-${\kappa}B$-dependent endothelin-1 expression in hepatic macrophages. J Immunol 2015;195:3866-79.   DOI
16 Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000;24:345-50.   DOI
17 Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L, et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010;51:514-21.   DOI
18 Deshpande G, Simmer K, Deshmukh M, Mori TA, Croft KD, Kristensen J. Fish oil (SMOFlipid) and olive oil lipid (Clinoleic) in very preterm neonates. J Pediatr Gastroenterol Nutr 2014;58:177-82.   DOI
19 Goulet O, Olieman J, Ksiazyk J, Spolidoro J, Tibboe D, Kohler H, et al. Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr 2013;32:162-71.   DOI
20 Wu J, Tang Q, Feng Y, Huang J, Tao Y, Wang Y, et al. Nutrition assessment in children with short bowel syndrome weaned off parenteral nutrition: a long-term follow-up study. J Pediatr Surg 2007;42:1372-6.   DOI
21 Parvadia JK, Keswani SG, Vaikunth S, Maldonado AR, Marwan A, Stehr W, et al. Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am J Physiol Gastrointest Liver Physiol 2007;293:G591-8.   DOI
22 Helmrath MA, Shin CE, Fox JW, Erwin CR, Warner BW. Adaptation after small bowel resection is attenuated by sialoadenectomy: the role for endogenous epidermal growth factor. Surgery 1998;124:848-54.   DOI
23 Olieman JF, Penning C, Ijsselstijn H, Escher JC, Joosten KF, Hulst JM, et al. Enteral nutrition in children with short-bowel syndrome: current evidence and recommendations for the clinician. J Am Diet Assoc 2010;110:420-6.   DOI
24 Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 2012;96:544-51.   DOI
25 Capriati T, Nobili V, Stronati L, Cucchiara S, Laureti F, Liguori A, et al. Enteral nutrition in pediatric intestinal failure: does initial feeding impact on intestinal adaptation? Expert Rev Gastroenterol Hepatol 2017;11:741-8.   DOI
26 Mezoff EA, Hawkins JA, Ollberding NJ, Karns R, Morrow AL, Helmrath MA. The human milk oligosaccharide 2′-fucosyllactose augments the adaptive response to extensive intestinal. Am J Physiol Gastrointest Liver Physiol 2016;310:G427-38.   DOI
27 Wanten G, Beunk J, Naber A, Swinkels D. Tocopherol isoforms in parenteral lipid emulsions and neutrophil activation. Clin Nutr 2002;21:417-22.   DOI
28 Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-32.
29 Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998;14:158-64.   DOI
30 Forchielli ML, Bersani G, Tala S, Grossi G, Puggioli C, Masi M. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. Lipids 2010;45:63-71.   DOI
31 Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr 2000;19:177-84.   DOI
32 Gandullia P, Lugani F, Costabello L, Arrigo S, Calvi A, Castellano E, et al. Long-term home parenteral nutrition in children with chronic intestinal failure: a 15-year experience at a single Italian centre. Dig Liver Dis 2011;43:28-33.   DOI
33 Urla C, Lieber J, Obermayr F, Busch A, Schweizer R, Warmann SW, et al. Surgical treatment of children with total colonic aganglionosis: functional and metabolic long-term outcome. BMC Surg 2018;18:58.   DOI
34 Muhammed R, Bremner R, Protheroe S, Johnson T, Holden C, Murphy MS. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr 2012;54:797-802.   DOI
35 Anez-Bustillos L, Dao DT, Fell GL, Baker MA, Gura KM, Bistrian BR, et al. Redefining essential fatty acids in the era of novel intravenous lipid emulsions. Clin Nutr 2018;37:784-9.   DOI
36 Baker MA, Mitchell PD, O'Loughlin AA, Potemkin AK, Anez-Bustillos L, Dao DT, et al. Characterization of fatty acid profiles in infants with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr 2018;42:71-7.
37 Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP, Wu J, Koletzko B, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr 2018;37:2324-36.   DOI
38 Kimura O, Ono S, Furukawa T, Higuchi K, Deguchi E, Iwai N. Management strategies for infants with total intestinal aganglionosis. J Pediatr Surg 2009;44:1564-7.   DOI
39 Colomb V, Dabbas-Tyan M, Taupin P, Talbotec C, Revillon Y, Jan D, et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr 2007;44:347-53.   DOI
40 Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 2011;60:17-25.   DOI
41 Wiskin AE, Cole C, Owens DR, Morgan M, Burge DM, Beattie RM. Ten-year experience of home parenteral nutrition in a single centre. Acta Paediatr 2012;101:524-7.   DOI
42 Lezo A, Capriati T, Spagnuolo MI, Lacitignola L, Goreva I, Di Leo G, et al. Paediatric home artificial nutrition in Italy: report from 2016 survey on behalf of artificial nutrition network of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP). Nutrients 2018;10:E1311.   DOI
43 Kim HB, Lee PW, Garza J, Duggan C, Fauza D, Jaksic T. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg 2003;38:881-5.   DOI
44 Charbit-Henrion F, Chardot C, Ruemmele F, Talbotec C, Morali A, Goulet O, et al. Anastomotic ulcerations after intestinal resection in infancy. J Pediatr Gastroenterol Nutr 2014;59:531-6.   DOI
45 Fremond ML, Viala J, Treton X, Roy M, Berrebi D, Gottrand F, et al. Digestive perianastomotic ulcerations and Crohn's disease. J Crohns Colitis 2014;8:1624-31.   DOI
46 Bianchi A. Intestinal loop lengthening--a technique for increasing small intestinal length. J Pediatr Surg 1980;15:145-51.   DOI
47 Sudan D, Thompson J, Botha J, Grant W, Antonson D, Raynor S, et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007;246:593-601.   DOI
48 Diamanti A, Fiocchi AG, Capriati T, Panetta F, Pucci N, Bellucci F, et al. Cow's milk allergy and neonatal short bowel syndrome: comorbidity or true association? Eur J Clin Nutr 2015;69:102-6.   DOI
49 Barclay AR, Henderson P, Gowen H, Puntis J; BIFS collaborators. The continued rise of paediatric home parenteral nutrition use: implications for service and the improvement of longitudinal data collection. Clin Nutr 2015;34:1128-32.   DOI
50 Petit LM, Girard D, Ganousse-Mazeron S, Talbotec C, Pigneur B, Elie C, et al. Weaning off prognosis factors of home parenteral nutrition for children with primary digestive disease. J Pediatr Gastroenterol Nutr 2016;62:462-8.   DOI
51 Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998;26:123-8.   DOI
52 De Greef E, Mahler T, Janssen A, Cuypers H, Veereman-Wauters G. The influence of neocate in paediatric short bowel syndrome on PN weaning. J Nutr Metab 2010;2010:297575.
53 Norsa L, Lambe C, Abi Abboud S, Barbot-Trystram L, Ferrari A, Talbotec C, et al.. The colon as an energy salvage organ for children with short bowel syndrome. Am J Clin Nutr 2019;109:1112-8.   DOI
54 Tappenden KA, Thomson AB, Wild GE, McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology 1997;112:792-802.   DOI
55 Bartholome AL, Albin DM, Baker DH, Holst JJ, Tappenden KA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr 2004;28:210-22.   DOI
56 Reigstad CS, Salmonson CE, Rainey JF 3rd, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 2015;29:1395-403.   DOI
57 Thompson J, Sudan D. Intestinal lengthening for short bowel syndrome. Adv Surg 2008;42:49-61.   DOI
58 de Boissieu D, Dupont C. Allergy to extensively hydrolyzed cow's milk proteins in infants: safety and duration of amino acid-based formula. J Pediatr 2002;141:271-3.   DOI
59 Bianchi A, Morabito A. The dilated bowel: a liability and an asset. Semin Pediatr Surg 2009;18:249-57.   DOI
60 Modi BP, Javid PJ, Jaksic T, Piper H, Langer M, Duggan C, et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007;204:365-71.   DOI
61 Ramos-Gonzalez G, Kim HB. Autologous intestinal reconstruction surgery. Semin Pediatr Surg 2018;27:261-6.   DOI
62 Abi Nader E, Lambe C, Talbotec C, Dong L, Pigneur B, Goulet O. A new concept to achieve optimal weight gain in malnourished infants on total parenteral nutrition. JPEN J Parenter Enteral Nutr 2018;42:78-86.
63 Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 2006;130:S16-28.   DOI
64 Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R, et al.; Parenteral Nutrition Guidelines Working Group 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005;41 Suppl 2:S1-87.   DOI
65 Mihatsch W, Shamir R, van Goudoever JB, Fewtrell M, Lapillonne A, Lohner S, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: guideline development process for the updated guidelines. Clin Nutr 2018;37:2306-8.   DOI
66 Ziegler MM, Royal RE, Brandt J, Drasnin J, Martin LW. Extended myectomy-myotomy. A therapeutic alternative for total intestinal aganglionosis. Ann Surg 1993;218:504-9.   DOI
67 Barrett M, Demehri FR, Ives GC, Schaedig K, Arnold MA, Teitelbaum DH. Taking a STEP back: assessing the outcomes of multiple STEP procedures. J Pediatr Surg 2017;52:69-73.   DOI
68 Oliveira C, de Silva N, Wales PW. Five-year outcomes after serial transverse enteroplasty in children with short bowel syndrome. J Pediatr Surg 2012;47:931-7.   DOI
69 Mutanen A, Barrett M, Feng Y, Lohi J, Rabah R, Teitelbaum DH, et al. Short bowel mucosal morphology, proliferation and inflammation at first and repeat STEP procedures. J Pediatr Surg 2019;54:511-6.   DOI
70 Fusaro F, Morini F, Mutanen A, De Angelis P, Tambucci R, Capriati T, et al. Autologous intestinal reconstructive surgery in the management of total intestinal aganglionosis. J Pediatr Gastroenterol Nutr 2019;68:635-41.   DOI
71 Matarese LE, Abu-Elmagd K. Somatropin for the treatment of short bowel syndrome in adults. Expert Opin Pharmacother 2005;6:1741-50.   DOI
72 Abi Nader E, Lambe C, Talbotec C, Pigneur B, Lacaille F, Garnier-Lengline H, et al. Outcome of home parenteral nutrition in 251 children over a 14-y period: report of a single center. Am J Clin Nutr 2016;103:1327-36.   DOI
73 Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-505.   DOI
74 Bailly-Botuha C, Colomb V, Thioulouse E, Berthe MC, Garcette K, Dubern B, et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res 2009;65:559-63.   DOI
75 Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. Eur J Gastroenterol 2018;6:181-91.   DOI
76 Diamanti A, Conforti A, Panetta F, Torre G, Candusso M, Bagolan P, et al. Long-term outcome of home parenteral nutrition in patients with ultra-short bowel syndrome. J Pediatr Gastroenterol Nutr 2014;58:438-42.   DOI
77 Ganousse-Mazeron S, Lacaille F, Colomb-Jung V, Talbotec C, Ruemmele F, Sauvat F, et al. Assessment and outcome of children with intestinal failure referred for intestinal transplantation. Clin Nutr 2015;34:428-35.   DOI
78 Hill S, Ksiazyk J, Prell C, Tabbers M, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: home parenteral nutrition. Clin Nutr 2018;37:2401-8.   DOI
79 Sudan D, DiBaise J, Torres C, Thompson J, Raynor S, Gilroy R, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005;9:165-76.   DOI
80 Koruda MJ, Rolandelli RH, Settle RG, Zimmaro DM, Rombeau JL. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection. Gastroenterology 1988;95:715-20.   DOI
81 Mayeur C, Gratadoux JJ, Bridonneau C, Chegdani F, Larroque B, Kapel N, et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One 2013;8:e54335.   DOI
82 Joly F, Mayeur C, Messing B, Lavergne-Slove A, Cazals-Hatem D, Noordine ML, et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2009;297:G116-23.   DOI
83 Kaneko T, Bando Y, Kurihara H, Satomi K, Nonoyama K, Matsuura N. Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli. J Clin Microbiol 1997;35:3181-5.   DOI
84 Engstrand Lilja H, Wefer H, Nystrom N, Finkel Y, Engstrand L. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome 2015;3:18.   DOI
85 Davidovics ZH, Carter BA, Luna RA, Hollister EB, Shulman RJ, Versalovic J. The fecal microbiome in pediatric patients with short bowel syndrome. JPEN J Parenter Enteral Nutr 2016;40:1106-13.   DOI
86 Grant D, Abu-Elmagd K, Mazariegos G, Vianna R, Langnas A, Mangus R, et al. Intestinal transplant registry report: global activity and trends. Am J Transplant 2015;15:210-9.   DOI
87 Torres C, Sudan D, Vanderhoof J, Grant W, Botha J, Raynor S, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr 2007;45:204-12.   DOI
88 Beath S, Pironi L, Gabe S, Horslen S, Sudan D, Mazeriegos G, et al. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation 2008;85:1378-84.   DOI
89 Javid PJ, Malone FR, Reyes J, Healey PJ, Horslen SP. The experience of a regional pediatric intestinal failure program: successful outcomes from intestinal rehabilitation. Am J Surg 2010;199:676-9.   DOI
90 Kadakia SC. D-lactic acidosis in a patient with jejunoileal bypass. J Clin Gastroenterol 1995;20:154-6.   DOI
91 Petersen C. D-lactic acidosis. Nutr Clin Pract 2005;20:634-45.   DOI
92 Hudson M, Pocknee R, Mowat NA. D-lactic acidosis in short bowel syndrome--an examination of possible mechanisms. Q J Med 1990;74:157-63.
93 Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004;39:634-6.   DOI
94 Carter BA, Cohran VC, Cole CR, Corkins MR, Dimmitt RA, Duggan C, et al. Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr 2017;181:102-111.e5.   DOI
95 Goulet O, Dabbas-Tyan M, Talbotec C, Kapel N, Rosilio M, Souberbielle JC, et al. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome. JPEN J Parenter Enteral Nutr 2010;34:513-20.   DOI
96 Peretti N, Loras-Duclaux I, Kassai B, Restier-Miron L, Guimber D, Gottrand F, et al. Growth hormone to improve short bowel syndrome intestinal autonomy: a pediatric randomized open-label clinical trial. JPEN J Parenter Enteral Nutr 2011;35:723-31.   DOI
97 Wales PW, Nasr A, de Silva N, Yamada J. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev 2010:CD006321.
98 Jeppesen PB. Gut hormones in the treatment of short-bowel syndrome and intestinal failure. Curr Opin Endocrinol Diabetes Obes 2015;22:14-20.   DOI
99 Wilhelm SM, Lipari M, Kulik JK, Kale-Pradhan PB. Teduglutide for the treatment of short bowel syndrome. Ann Pharmacother 2014;48:1209-13.   DOI
100 Ben Lulu S, Coran AG, Shehadeh N, Shamir R, Mogilner JG, Sukhotnik I. Oral insulin stimulates intestinal epithelial cell turnover following massive small bowel resection in a rat and a cell culture model. Pediatr Surg Int 2012;28:179-87.   DOI
101 Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 2009;28:88-93.   DOI
102 McMellen ME, Wakeman D, Longshore SW, McDuffie LA, Warner BW. Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 2010;19:35-43.   DOI
103 Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 1999;11:141-61.   DOI
104 Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 2009;14:256-61.   DOI
105 Kaufman SS, Pehlivanova M, Fennelly EM, Rekhtman YM, Gondolesi GE, Little CA, et al. Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J Pediatr 2010;156:580-585.e1.   DOI
106 Pichler J, Horn V, Macdonald S, Hill S. Intestinal failure-associated liver disease in hospitalised children. Arch Dis Child 2012;97:211-4.   DOI
107 Takahashi K, Terashima H, Kohno K, Ohkohchi N. A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome. Int Surg 2013;98:110-3.   DOI
108 Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med 1995;122:839-42.   DOI
109 Cole CR, Frem JC, Schmotzer B, Gewirtz AT, Meddings JB, Gold BD, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr 2010;156:941-947.e1.   DOI
110 Gutierrez IM, Kang KH, Calvert CE, Johnson VM, Zurakowski D, Kamin D, et al. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review. J Pediatr Surg 2012;47:1150-4.   DOI
111 Struijs MC, Diamond IR, de Silva N, Wales PW. Establishing norms for intestinal length in children. J Pediatr Surg 2009;44:933-8.   DOI
112 Goulet O, Lambe C. Intravenous lipid emulsions in pediatric patients with intestinal failure. Curr Opin Organ Transplant 2017;22:142-8.   DOI
113 Velazco CS, Fullerton BS, Brazzo JA 3rd, Hong CR, Jaksic T, Barnewolt CE. Radiographic measurement of intestinal length among children with short bowel syndrome: retrospective determination remains problematic. J Pediatr Surg 2017;52:1921-4.   DOI
114 Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut 1991;32:1321-3.   DOI
115 Ricour C, Duhamel JF, Arnaud-Battandier F, Collard Y, Revillon Y, Nihoul-Fekete C. Enteral and parenteral nutrition in the short bowel syndrome in children. World J Surg 1985;9:310-5.   DOI
116 Goulet OJ, Revillon Y, Jan D, De Potter S, Maurage C, Lortat-Jacob S, et al. Neonatal short bowel syndrome. J Pediatr 1991;119:18-23.   DOI
117 D'Antiga L, Goulet O. Intestinal failure in children: the European view. J Pediatr Gastroenterol Nutr 2013;56:118-26.   DOI
118 Norsa L, Gupte G, Ramos Boluda E, Joly F, Corcos O, Pirenne J, et al. Life of patients 10 years after a successful pediatric intestinal transplantation in Europe. Am J Transplant 2018;18:1489-93.   DOI
119 Pironi L, Forbes A, Joly F, Colomb V, Lyszkowska M, Van Gossum A, et al. Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology 2008;135:61-71.   DOI
120 Quigley EMM. The spectrum of small intestinal bacterial overgrowth (SIBO). Curr Gastroenterol Rep 2019;21:3.   DOI
121 Triantafyllou K, Sioulas AD, Giamarellos-Bourboulis EJ. Rifaximin: the revolutionary antibiotic approach for irritable bowel syndrome. Mini Rev Med Chem 2015;16:186-92.   DOI
122 Rosania R, Giorgio F, Principi M, Amoruso A, Monno R, Di Leo A, et al. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol 2013;8:169-72.   DOI
123 Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005;40:755-62.   DOI
124 Sauvat F, Grimaldi C, Lacaille F, Ruemmele F, Dupic L, Bourdaud N, et al. Intestinal transplantation for total intestinal aganglionosis: a series of 12 consecutive children. J Pediatr Surg 2008;43:1833-8.   DOI
125 Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005;242:403-9.   DOI
126 Pironi L, Hebuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 2006;101:1633-43.   DOI
127 Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr 2012;31:831-45.   DOI
128 Norsa L, Artru S, Lambe C, Talbotec C, Pigneur B, Ruemmele F, et al. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: parenteral nutrition or intestinal transplantation. Clin Nutr 2019;38:926-33.   DOI
129 Taha AM, Sharif K, Johnson T, Clarke S, Murphy MS, Gupte GL. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease. J Pediatr Gastroenterol Nutr 2012;54:547-51.   DOI
130 Lacaille F, Irtan S, Dupic L, Talbotec C, Lesage F, Colomb V, et al. Twenty-eight years of intestinal transplantation in Paris: experience of the oldest European center. Transpl Int 2017;30:178-86.   DOI
131 Merritt RJ, Cohran V, Raphael BP, Sentongo T, Volpert D, Warner BW, et al. Intestinal rehabilitation programs in the management of pediatric intestinal failure and short bowel syndrome. J Pediatr Gastroenterol Nutr 2017;65:588-96.   DOI
132 Nucci A, Burns RC, Armah T, Lowery K, Yaworski JA, Strohm S, et al. Interdisciplinary management of pediatric intestinal failure: a 10-year review of rehabilitation and transplantation. J Gastrointest Surg 2008;12:429-35.   DOI
133 Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009;19:348-53.   DOI
134 Fullerton BS, Hong CR, Jaksic T. Long-term outcomes of pediatric intestinal failure. Semin Pediatr Surg 2017;26:328-35.   DOI
135 Totonelli G, Tambucci R, Boscarelli A, Hermans D, Dall'Oglio L, Diamanti A, et al. Pediatric intestinal rehabilitation and transplantation registry: initial report from a European Collaborative Registry. Eur J Pediatr Surg 2018;28:75-80.   DOI
136 Lambe C, Poisson C, Talbotec C, Goulet O. Strategies to reduce catheter-related bloodstream infections in pediatric patients receiving home parenteral nutrition: the efficacy of taurolidine-citrate prophylactic-locking. JPEN J Parenter Enteral Nutr 2018;42:1017-25.   DOI
137 Kawano T, Kaji T, Onishi S, Yamada K, Yamada W, Nakame K, et al. Efficacy of ethanol locks to reduce the incidence of catheter-related bloodstream infections for home parenteral nutrition pediatric patients: comparison of therapeutic treatment with prophylactic treatment. Pediatr Surg Int 2016;32:863-7.   DOI
138 Hukkinen M, Mutanen A, Pakarinen MP. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury. Surgery 2017;162:670-9.   DOI
139 Iacono G, Carroccio A, Montalto G, Cavataio F, Lo Cascio M, Notarbatolo A. Extreme short bowel syndrome: a case for reviewing the guidelines for predicting survival. J Pediatr Gastroenterol Nutr 1993;16:216-9.   DOI
140 Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr 2012;161:723-728.e2.   DOI
141 Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2010;34:32-7.   DOI
142 Sala D, Chomto S, Hill S. Long-term outcomes of short bowel syndrome requiring long-term/home intravenous nutrition compared in children with gastroschisis and those with volvulus. Transplant Proc 2010;42:5-8.   DOI
143 Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001;139:27-33.   DOI
144 Quiros-Tejeira RE, Ament ME, Reyen L, Herzog F, Merjanian M, Olivares-Serrano N, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004;145:157-63.   DOI
145 Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005;15:95-101.   DOI
146 Nusinovich Y, Revenis M, Torres C. Long-term outcomes for infants with intestinal atresia studied at Children's National Medical Center. J Pediatr Gastroenterol Nutr 2013;57:324-9.   DOI
147 Belza C, Fitzgerald K, de Silva N, Avitzur Y, Steinberg K, Courtney-Martin G, et al. Predicting intestinal adaptation in pediatric intestinal failure: a retrospective cohort study. Ann Surg 2019;269:988-93.   DOI
148 Khen-Dunlop N, Sarnacki S, Victor A, Grosos C, Menard S, Soret R, et al. Prenatal intestinal obstruction affects the myenteric plexus and causes functional bowel impairment in fetal rat experimental model of intestinal atresia. PLoS One 2013;8:e62292.   DOI
149 Moseley RH. Sepsis and cholestasis. Clin Liver Dis 2004;8:83-94.   DOI
150 Hukkinen M, Kivisaari R, Merras-Salmio L, Koivusalo A, Pakarinen MP Small bowel dilatation predicts prolonged parenteral nutrition and decreased survival in pediatric short bowel syndrome. Ann Surg 2017;266:369-75.   DOI
151 Jones A, Selby PJ, Viner C, Hobbs S, Gore ME, McElwain TJ. Tumour necrosis factor, cholestatic jaundice, and chronic liver disease. Gut 1990;31:938-9.   DOI
152 Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006;3:574-85.   DOI
153 Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007;44:459-63.   DOI
154 Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol 2009;51:565-80.   DOI
155 Abu-Elmagd K. The concept of gut rehabilitation and the future of visceral transplantation. Nat Rev Gastroenterol Hepatol 2015;12:108-20.   DOI
156 Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:753-71.   DOI
157 Goulet OJ. Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions. World Rev Nutr Diet 2015;112:90-114.   DOI